Xuyuan Dong

1. Claudin 18.2 is a potential therapeutic target for zolbetuximab in pancreatic ductal adenocarcinoma
   2022/07/07 by Xi Wang, Chengsheng Zhang, Xuyuan Dong +15 · 1 voice · 1 citation
   Biochemistry, Genetics and Molecular Biology · Medicine · Neuroscience · #Barrier Structure and Function Studies #Caveolin-1 and cellular processes #Cell Adhesion Molecules Research